This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Martin R Leivers: Innovator in Viral Infection Treatment
Introduction
Martin R Leivers is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating viral infections.
Latest Patents
Leivers holds a patent for 5,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of use. This patent focuses on compounds that serve as inhibitors for hepatitis B virus and/or hepatitis D virus. Specifically, these compounds inhibit HBe antigen and HBs antigen in a subject, providing a potential treatment for viral infections.
Career Highlights
Martin R Leivers is associated with GlaxoSmithKline Intellectual Property Development Limited, where he has been instrumental in advancing research and development in antiviral therapies. His work has contributed to the understanding and treatment of hepatitis-related conditions.
Collaborations
Leivers has collaborated with esteemed colleagues such as John G Catalano and Pek Yoke Chong, enhancing the research efforts within his field.
Conclusion
Martin R Leivers stands out as an innovator in the pharmaceutical industry, particularly in the fight against viral infections. His contributions through patents and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile